It is possible to re-engineer computer systems so they can't be hacked, says MIT's Howard Shrobe. » Read More
By: Vasant Dhar, professor at NYU Stern School of Business
Data recorded by autonomous vehicles will make it easier to find out how and why accidents happen, says NYU professor Vasant Dhar. » Read More
Virginia is one typically red state that Trump will never win. And it's not for the reasons you think, says Jake Novak.
An op-ed by a venture capitalist in the Wall Street Journal has some unbelievably sexist advice for women in tech, says The Verge's T.C. Sottek.
Presidents need to hear bad news. Donald Trump can't handle it, says Vox's Dara Lind.
Elderly voters are a crucial voting block and Donald Trump has found a new way to connect with them, says Jake Novak.
Investor Richard Hurowitz says Shimon Peres was a humble statesman—pretty much an anti-Trump. He shares some great lessons from the former Israeli president.
This election is hardly in the bag for Clinton, says "Young Turks" reporter Jordan Chariton. Here's where she remains vulnerable.
Hedge funds aren't going away but there is a massive shift happening in the industry, explains finanical advisor Josh Brown.
Clinton campaign strategists are becoming increasingly worried about carrying the Sunshine State. Here's why, says senior columnist Jake Novak.
The next president, far from preventing it, will be left to deal with a recession and the aftermath, says market analyst Peter Boockvar.
The debate was more embarrassing than illuminating, says senior columnist Jake Novak. And the biggest loser is...
We are arguably at a place of crisis in the cybersecurity war, these security experts say. Here, they explain a two-part solution.
Trump didn't make any major stumbles or gaffes, which means he won the debate and could win in November, says GOP strategist Sara Fagen.
Trump started the debate strong, but then he played right into Clinton's hands, says Democratic strategist Chris Kofinis.
In the first debate, Clinton scored more points than Trump and emerged "unscathed," says Bradely Tusk.
Every pharma CEO needs to step up and say these outrageous drug-price hikes are not OK, says former Medtronic CEO Bill George. e.
Donald Trump got sidetracked too often in the first debate and missed two opportunities to score major debate points, says Jake Novak.